Westlake Village BioPartners — Full Portfolio

Alumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases.

AI & Machine LearningBiotechDigital HealthHealthtechLongevitySouth San Francisco, US

MBMartin Babler(President, Chief Executive Officer and Chairman of the Board)inMBMark Bradley(Chief Development Officer)inKBKolbot By(SVP, Head of Technical Operations)inJDJack Danilkowicz(Chief Commercial Officer)inJDJörn Drappa(Chief Medical Officer)inDMDavid M Goldstein(Chief Scientific Officer)in

Co-investorsFOForesite CapitalGEGeneral AtlanticHBHBM Healthcare InvestmentsHBHBM PartnersNENextech InvestOROrbiMed+4 more

Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.

BiotechEmeryville, US

WBWarner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)PMPeter Maag(Executive Officer, Director)in

Co-investorsBABain Capital Life SciencesVIVida VenturesGIGilead SciencesINInsight PartnersKLKleiner PerkinsNONorthpond Ventures+3 more

Capsida Biotherapeutics develops engineered gene therapies for rare and common neurological and ocular diseases using an AAV capsid platform that enables improved brain and retinal delivery compared to naturally occurring capsids.

BiotechDeep TechDigital HealthMedical Devices

Viviana GradinaruNick Goeden, Ph.D.(Co-founder)NFNicholas Flytzanis(Co-founder)in

Co-investorsVEVersant Ventures

Arpeggio Bio develops pharmaceutical drugs that target transcription factors using artificial intelligence and RNA-sequencing technology, with lead programs in development for melanoma treatment and rare disease applications.

BiotechHealthtechBoulder, US

JAJoey Azofeifa(Founder)inLNLaura Norris(Executive Officer, Director)inTimothy Read(Executive Officer, Director)Eric Martin(Executive Officer)in

BoardAmit Mehta(Director)

Board seatDADavid AllisonMCMira Chaurushiya· per SEC Form D

Co-investorsATATEM Capital FundFIFifty YearsFUFundersClubTATau VenturesVEvenBio PartnersY Y Combinator+9 more

Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.

BiotechHealthtechMedical DevicesSouth San Francisco, US

KDKen Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)

Board seatBSBeth Seidenberg· per SEC Form D

Co-investorsARARCH Venture PartnersHIHitachi VenturesKLKleiner PerkinsLULuma GroupOUOUP (Osage University Partners)SOSoftBank Vision Fund+4 more

Impel Pharmaceuticals develops therapies for diseases with high unmet medical needs by pairing established drugs with its proprietary upper-nasal drug delivery technology.

BiotechHealthtechMedical DevicesSeattle, US

JDJohn D. Hoekman(Executive Officer, Director)in

BoardMichael Hite(Director)Stewart Parker(Director)

Board seatDADavid Allison· per SEC Form D · $1.9M raise · filed Apr 2021

Co-investors5A5AM VenturesB B Capital GroupVEvenBio Global StrategicVEvenBio Partners

Latigo Biotherapeutics is a clinical-stage biopharmaceutical company developing non-opioid pain medicines designed to stop pain transmission without addiction risk.

BiotechHealthtechMedical DevicesThousand Oaks, US

NFNima Farzan(Executive Officer, Director)TLTim Lugo(Executive Officer)Sean Harper Desmond Padhi(Founder)

BoardJTJim Tananbaum(Director)inDPDeborah Palestrant(Director)in

Board seatBSBeth Seidenberg· per SEC Form D

Co-investors5A5AM VenturesACAccess BiotechnologyASAscenta CapitalFOForesite CapitalKEKern Capital, LLCSASanofi Ventures

Neurogastrx is a biopharmaceutical company developing therapies for patients with gastrointestinal disorders.

BiotechHealthtechWoburn, US

CDCyril De Colle(Founder)inJAMES DETORE(Executive Officer)JOJAMES O'MARA(Executive Officer, Director)inPAUL ROGERS(Executive Officer)in

BoardKVKLAUS VEITINGER(Director)in

Board seatDADavid Allison· per SEC Form D

Co-investors5A5AM VenturesOROrbiMedSASamsara BioCapitalVEvenBio PartnersVIVivo CapitalRTRTW Investments L.P.+1 more

Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.

BiotechDeep TechHealthtechMedical DevicesWellness & FitnessSan Francisco, US

Jim Wells(Co-founder, Scientific Advisory Board Chair)KMKristine M Ball(Executive Officer, Director)inZHZachary Hill(Executive Officer, Director)in

BoardNisha Marathe(Director)KGKeno Gutierrez(Director)in

Board seatDADavid Allison· per SEC Form D

Co-investors5A5AM VenturesNONovartis Venture FundRORoche Venture FundVEVersant VenturesBIBioGeneration Ventures

Star Therapeutics develops treatments aimed at addressing real-world patient needs.

BiotechSouth San Francisco, US

ARAdam Rosenthal(Founder & CEO)inNSNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)SRScott Robertson(Executive Officer)inGary Patou(Executive Officer)in

Board seatBSBeth Seidenberg· per SEC Form D

Co-investorsFRFrazier Life SciencesOROrbiMedRARA CapitalSASanofi VenturesSOSofinnova VenturesVIViking Global+11 more

3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets.

AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US

KCK. Christopher Garcia(Co-Founder, Chairman of the Scientific Advisory Board)MGMarvin Gee(Co-Founder, Chief Research Officer)inStefan Scherer, MD, PhD(Chief Executive Officer & President)Leah Sibener, PhD(3T Co-Founder and Scientific Advisor)

Co-investorsASAsset Management CompanyCOCollaborative FundCRCRV (Charles River Ventures)MEMenlo VenturesOSOS FundSTStarlight Ventures+1 more

AI & Machine LearningBiotechDigital HealthHealthtech

Co-investorsDEDecheng CapitalSASamsara BioCapitalVEvenBio PartnersACAccess IndustriesKLKleiner Perkins

Akamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life.

BiotechDigital HealthHealthtechMedical DevicesCambridge, MA, US

Howard Davis, PhD(Chief Executive Officer)

Co-investorsARARCH Venture PartnersSRSR One Capital ManagementIPIP GroupLULundbeckfonden Ventures

AllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions.

BiotechNatick, US

CPCatherine Pearce(CEO & Founder)inDHSc(Founder)JRJustin R Thompson(Founder)in

Co-investorsVEVersant VenturesWEWestlake BioPartners

Borealis develops RNA medicines to treat kidney diseases.

BiotechDigital Health

Co-investorsVEVersant Ventures

Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment.

BiotechHealthtechMedical DevicesSouth San Francisco, US

ARAdam Rosenthal(Co-founder and former CEO; Director)inQuehuong (Kathy) Dong, Pharm.D.(Executive Officer, Director)Kathy Dong(President, Chief Executive Officer and Director)in

BoardBeth Seidenberg, M.D.(Director)Thomas Geninatti, Ph.D.(Director)Carl Gordon, Ph.D.(Director)

Co-investorsHBHBM Healthcare InvestmentsHBHBM PartnersOROrbiMedRARA CapitalKLKleiner PerkinsNVNVIDIA

A patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases.

BiotechSan Diego, US

Kevin Forrest, Ph.D.(Executive Officer, Director)

BoardClare Ozawa, Ph.D.(Director)Beth Seidenberg, M.D.(Director)

Co-investorsOUOUP (Osage University Partners)KLKleiner PerkinsVEVersant Ventures

Magnetic Particle Imaging (MPI) is an imaging technology that detects iron oxide nanoparticle tracers using time-varying magnetic fields to create medical images with high contrast and sensitivity.

Deep TechHealthtechMedical Devices

Co-investors5A5AM VenturesAIAimTop VenturesALAlumni VenturesCLCloudStone CapitalEVEvolution VC PartnersGAGaingels+4 more

Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease.

AI & Machine LearningBiotechDeep TechDigital HealthSouth San Francisco, US

NSNancy Stagliano(CEO)in

Co-investorsHBHBM Healthcare InvestmentsHBHBM PartnersKLKleiner PerkinsSOSoftBank GroupSOSoftBank Vision FundACACORN BIOVENTURES+2 more

Oorja Bio is a biotechnology company developing therapies focused on fibrotic disease, aiming to repair, reverse, and remodel fibrosis.

BiotechHealthtech

SKSujay Kango(Chief Executive Officer & Founder)inJPJanethe Pena(Chief Medical Officer & Founder)inCCConnie Coulomb(Chief Business Officer & Founder)in

Co-investorsANAndreessen HorowitzKLKleiner PerkinsWEWestlake BioPartners

Qumis provides an AI platform built for insurance coverage attorneys and law firms that analyzes complex insurance policies and programs, producing cited, confidence-scored comparisons, checklists, opinions, and client-ready deliverables.

AI & Machine LearningInsurTechLegalTechChicago, US

Shivam Sinha(Executive Officer, Director)Dan Schuleman(Executive Officer, Director)

BoardBMBrian McLoughlin(Director)inNJNeenah Jain(Director)in

Co-investorsALAlumni VenturesAMAmerican Family VenturesARArmory Square VenturesMTMTECH CAPITAL

BiotechMenlo Park, US

BEBrett Ewald(Executive Officer)inUmesh Gangadharmath(Executive Officer)inIMIstvan Molnar(Executive Officer)inYunfei Zhu(Executive Officer)Ana Kusnetzow(Executive Officer)inScott Struthers(Director)

Co-investorsDCDCVC (Data Collective)FRFrazier Life Sciences5A5AM VenturesDCDCVC BioFRFrazier Healthcare Partners

Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel.

AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US

NWNancy Whiting(CEO)in

Co-investorsACAccess BiotechnologyNENew Enterprise Associates (NEA)

Uprise builds AI-based financial tools aimed at small business owners, addressing their combined business and personal financial needs.

AI & Machine LearningEnterprise SoftwareFintechSaaSSan Francisco, US

NMNanthakumar Muthusamy(Founder)inCGChris Goodmacher(Co-Founder)inJCJessica Chen Riolfi(Co-Founder & CEO)in

Co-investorsBLBlank VenturesCOContraryGRGraham Walker VentureOXOxonian VenturesSESerac VenturesDADash Fund+2 more

Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies.

BiotechHealthtechMedical Devices

Co-investorsCACanaan Partners